BRIEF published on 03/11/2026 at 09:05, 13 days ago Aiforia Technologies Oyj enregistre une forte croissance clinique Marché Européen Amélioration De La Rentabilité Expansion De La Clientèle Position De Trésorerie Croissance Clinique
BRIEF published on 03/11/2026 at 09:05, 13 days ago Aiforia Technologies Oyj Sees Clinical Growth Surge European Market Cash Position Profitability Improvement Client Expansion Clinical Growth
PRESS RELEASE published on 03/11/2026 at 09:00, 13 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj by NuWays AG analyzed: Clinical growth accelerates, profitability improves with increased share of wallet and workforce reductions. Target price EUR 3.8 Profitability NuWays AG Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 03/09/2026 at 09:05, 15 days ago Aiforia Technologies Oyj prête pour la croissance dans le segment clinique Partenariats Stratégiques Part De Marché Amélioration De L'EBITDA Expansion Des Revenus Croissance Clinique
BRIEF published on 03/09/2026 at 09:05, 15 days ago Aiforia Technologies Oyj Poised for Growth in Clinical Segment Strategic Partnerships Revenue Expansion EBITDA Improvement Market Share Clinical Growth
PRESS RELEASE published on 03/09/2026 at 09:00, 15 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj's clinical segment shows strong growth with a clear roadmap for scaling, leading to improved profitability and strategic partnerships. Research recommends buying with a target price of EUR 3.80 Strategic Partnerships Profitability Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 02/27/2026 at 09:05, 25 days ago Aiforia Technologies Oyj Anticipates Strong Clinical Revenue Growth Strategic Partnerships AI Technology Profitability Financial Growth Clinical Revenue
BRIEF published on 02/27/2026 at 09:05, 25 days ago Aiforia Technologies Oyj anticipe une forte croissance de ses revenus cliniques Croissance Financière Rentabilité Partenariats Stratégiques Technologie IA Revenus Cliniques
PRESS RELEASE published on 02/27/2026 at 09:00, 25 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj's updated research report by NuWays AG reveals accelerated clinical revenue growth expectations, with key focus on AI technology adoption and strategic partnerships for sales growth NuWays AG Research Report Aiforia Technologies Oyj Clinical Revenue Growth AI Technology Adoption
BRIEF published on 02/11/2026 at 09:05, 1 month 13 days ago La voie innovante vers la rentabilité d'Aiforia Technologies Oyj Rentabilité Imagerie Médicale Technologies Aiforia Transformateur De Vision Moteur De Fondation
Published on 03/24/2026 at 08:01, 1 hour 11 minutes ago Star Copper Confirms Copper Creek Mineralization
Published on 03/24/2026 at 07:00, 2 hours 12 minutes ago Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 2 hours 12 minutes ago Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/23/2026 at 22:40, 10 hours 32 minutes ago Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/24/2026 at 09:05, 7 minutes ago Nagarro announces preliminary numbers for FY 2025, guidance for FY 2026, and conclusion of independent investigation
Published on 03/24/2026 at 09:05, 7 minutes ago MSI Highlights Cloud, AI, and Enterprise Server Platforms at CloudFest 2026
Published on 03/24/2026 at 09:02, 10 minutes ago EQS-Adhoc: PAUL Tech AG secures EUR 40 million credit facility to support further growth
Published on 03/24/2026 at 09:00, 11 minutes ago Original-Research: MAX Automation SE (von NuWays AG): BUY
Published on 03/24/2026 at 07:45, 1 hour 27 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 1 hour 27 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 1 hour 42 minutes ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
Published on 03/24/2026 at 07:30, 1 hour 42 minutes ago Gimv verzekert zich van een nieuwe Revolving Credit Facility van EUR 400 miljoen ter ondersteuning van de versnelde groeiambities
Published on 03/23/2026 at 19:08, 14 hours 4 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
